+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Conventional and Alternative Pain Treatment Market - Product Thumbnail Image

Conventional and Alternative Pain Treatment Market

  • Report
  • November 2024
  • 173 Pages
  • Global
From
Conventional and Alternative Pain Treatment Markets - Product Thumbnail Image

Conventional and Alternative Pain Treatment Markets

  • Report
  • November 2020
  • 260 Pages
  • Global
From
Global Market for Pain Management Drugs and Devices - Product Thumbnail Image

Global Market for Pain Management Drugs and Devices

  • Report
  • November 2023
  • 171 Pages
  • Global
From
Pain Management Devices - A Global Market Overview - Product Thumbnail Image

Pain Management Devices - A Global Market Overview

  • Report
  • November 2024
  • 261 Pages
  • Global
From
Pain Management Devices Market 2024-2028 - Product Thumbnail Image

Pain Management Devices Market 2024-2028

  • Report
  • July 2024
  • 172 Pages
  • Global
From
From
Post Operative Pain Management Global Market Report 2025 - Product Thumbnail Image

Post Operative Pain Management Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more